Traditionally, obesity and its related diseases have been considered a problem in Western
countries. However, in the past two decades, urbanisation in many Asian countries has led …

Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disease ranging from simple
steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) and fibrosis.“Obese/Metabolic …

Background Non-alcoholic fatty liver disease (NAFLD) is a common disorder that is known to
be the leading cause of chronic liver disease worldwide. This study aims to systematically …

Abstract Background and Aim Although non‐alcoholic fatty liver disease (NAFLD) is
common in the general population, identifying patients with advanced fibrosis remains a …

Metabolic-associated fatty liver disease (MAFLD) and its potential impact on the severity of
COVID-19 have gained significant attention during the pandemic. This review aimed to …

Nonalcoholic fatty liver disease (NAFLD) is a common liver disease with a wide spectrum of
liver conditions ranging from hepatic steatosis to nonalcoholic steatohepatitis (NASH) …

Non-alcoholic fatty liver disease (NAFLD) is a heterogeneous condition with a wide
spectrum of clinical presentations and natural history and disease severity. There is also …

Background Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) are
both shown to increase the risk of cardiovascular diseases and type 2 diabetes. However …

Two major causes of steatohepatitis are alcohol and metabolic syndrome. Although the
underlying causes of alcohol-related liver disease (ALD) and nonalcoholic fatty liver disease …

Nonalcoholic fatty liver disease (NAFLD) is defined by presence of steatosis in more than
5% of liver cells. The gold standard for diagnosis is liver biopsy, but this is seldom achieved …